Literature DB >> 27200161

Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tracts.

Mark Bang-Wei Tan1, Louis Elliott McAdory1.   

Abstract

An 80 year old lady with a history of metastatic sigmoid carcinoma presented with expressive dysphasia and unsteady gait 4 days after commencement of adjuvant capecitabine chemotherapy. MRI demonstrated restricted diffusion and T2/FLAIR hyperintensity involving the course of the bilateral corticospinal tracts, the corpus callosum and the middle cerebellar peduncles. Discontinuation of chemotherapy lead to symptom resolution in 2 days; repeat MRI at 2 months demonstrated reversal of the diffusion changes and improvement of the previous T2W/FLAIR hyperintensity. This report describes the first case of capecitabine induced leukoencephalopathy causing restricted diffusion along the corticospinal tracts, which should be differentiated from other entities that involve the corticospinal tracts (i.e. amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), hypoglycemic coma, etc.).

Entities:  

Keywords:  Capecitabine induced leukoencephalopathy; capecitabine toxicity; corpus callosum; corticospinal tracts; drug-induced leukoencephalopathy

Mesh:

Substances:

Year:  2016        PMID: 27200161      PMCID: PMC4861613          DOI: 10.3941/jrcr.v10i3.2686

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  32 in total

1.  Toxic encephalopathy induced by capecitabine.

Authors:  B Niemann; C Rochlitz; R Herrmann; M Pless
Journal:  Oncology       Date:  2004       Impact factor: 2.935

2.  Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma.

Authors:  T Aoki; T Sato; K Hasegawa; R Ishizaki; M Saiki
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

3.  Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Authors:  L Bezman; A B Moser; G V Raymond; P Rinaldo; P A Watkins; K D Smith; N E Kass; H W Moser
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

Review 4.  Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology.

Authors:  E Lyros; S Walter; I Keller; P Papanagiotou; K Fassbender
Journal:  Neurotoxicology       Date:  2014-03-11       Impact factor: 4.294

Review 5.  [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].

Authors:  Rai Shimoyama; Takushiro Ban; Katsunori Miyake; Naoko Isogai; Yuki Ikegaya; Jun Kawachi; Hidemitsu Ogino; Kazunao Watanabe
Journal:  Gan To Kagaku Ryoho       Date:  2014-10

Review 6.  The epidemiology of motor neuron diseases: a review of recent studies.

Authors:  P M Worms
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

7.  Early symptom progression rate is related to ALS outcome: a prospective population-based study.

Authors:  A Chiò; G Mora; M Leone; L Mazzini; D Cocito; M T Giordana; E Bottacchi; R Mutani
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

8.  Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy.

Authors:  D J Loes; A Fatemi; E R Melhem; N Gupte; L Bezman; H W Moser; G V Raymond
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

9.  Capecitabine-related neurotoxicity presenting as trismus.

Authors:  Linda S B Couch; David L Groteluschen; James A Stewart; Daniel L Mulkerin
Journal:  Clin Colorectal Cancer       Date:  2003-08       Impact factor: 4.481

10.  Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study.

Authors:  M S Heier; R Heintz; S D Fosså
Journal:  Acta Neurol Scand       Date:  1986-09       Impact factor: 3.209

View more
  3 in total

1.  Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.

Authors:  Alberto Vogrig; Bastien Joubert; Aurélien Maureille; Laure Thomas; Emilien Bernard; Nathalie Streichenberger; Francois Cotton; Francois Ducray; Jérome Honnorat
Journal:  J Neurol       Date:  2018-11-29       Impact factor: 4.849

2.  Differential Diagnoses of Amyotrophic Lateral Sclerosis are More Variegated than Anticipated.

Authors:  Josef Finsterer
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

3.  Case Report: MRI, Clinical, and Pathological Correlates of Bromethalin Toxicosis in Three Dogs.

Authors:  Vishal D Murthy; Ehren McLarty; Kevin D Woolard; Rell L Parker; Gregg Kortz; Jamie N King; Robert H Poppenga; Marguerite F Knipe; Peter J Dickinson
Journal:  Front Vet Sci       Date:  2022-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.